arctigenin has been researched along with Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, KS; Lee, MG; Nam, KS | 2 |
| Liu, XP; Shao, TL; Shen, XB; Wang, GD; Yuan, PC; Zhu, L | 1 |
| Dai, J; Dong, G; Fang, R; Fu, J; Guo, X; Li, C; Li, Z; Ma, Q; Ning, Z; Shi, H; Si, C; Xiong, H; Yan, F; Zhang, H; Zhang, J; Zhao, L | 1 |
| Lou, C; Zhao, H; Zhao, Y; Zhu, R; Zhu, Z | 1 |
| Chun, SY; Kim, S; Lee, KS; Maxwell, T; Nam, KS | 1 |
| Imm, JY; Lee, J; Lee, SH | 1 |
7 other study(ies) available for arctigenin and Breast Neoplasms
| Article | Year |
|---|---|
Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Necrosis | 2023 |
Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation.
Topics: Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Female; Furans; Glycogen Synthase Kinase 3; Humans; Lignans; MCF-7 Cells; Proteolysis; Receptors, Estrogen | 2020 |
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Breast Neoplasms; Cell Movement; Cell Proliferation; Cytokines; Female; Furans; Gene Expression Regulation, Neoplastic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lignans; Mice; Mice, Inbred BALB C; Mice, Nude; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Arctigenin-mediated cell death of SK-BR-3 cells is caused by HER2 inhibition and autophagy-linked apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Receptor, ErbB-2; Signal Transduction | 2021 |
Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells.
Topics: Animals; Arctium; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chick Embryo; Down-Regulation; Female; Furans; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronidase; Humans; Lignans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis | 2017 |
The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Female; Furans; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Lignans; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Metastasis; Phytoestrogens; Receptors, Estrogen; Signal Transduction; Urokinase-Type Plasminogen Activator | 2017 |
β-Catenin Mediates Anti-adipogenic and Anticancer Effects of Arctigenin in Preadipocytes and Breast Cancer Cells.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Antineoplastic Agents; Apoptosis; Asteraceae; beta Catenin; Breast Neoplasms; CCAAT-Enhancer-Binding Protein-alpha; Female; Furans; Humans; Lignans; Lipid Metabolism; Mice; Plant Extracts; PPAR gamma; Signal Transduction | 2017 |